Loading…
Vivimed Labs (VIVIMEDLAB)₹5.40−0.18%Pharmaceuticals
At the end of the Mar 2026 quarter, Vivimed Labs' shareholders were: promoters 7.54%, FIIs 1.65%, government 0.12%, public 90.69%. Promoter holding is down 0.19 percentage points from 7.73% a quarter earlier. 15.25% of promoter shares were pledged. It had 47,506 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 20.91% | 20.91% | 20.91% | 20.91% | 20.91% | 20.91% | 20.91% | 20.91% | 7.73% | 7.73% | 7.73% | 7.54% |
| FIIs | 1.65% | 1.65% | 1.65% | 1.65% | 1.65% | 1.65% | 1.65% | 1.65% | 1.65% | 1.65% | 1.65% | 1.65% |
| Government | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% |
| Public | 77.32% | 77.32% | 77.32% | 77.32% | 77.32% | 77.32% | 77.32% | 77.32% | 90.50% | 90.50% | 90.50% | 90.69% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 15.25% |
| Number of shareholders | 49,517 | 49,052 | 49,041 | 49,030 | 49,026 | 49,017 | 49,019 | 48,971 | 48,942 | 48,939 | 49,235 | 47,506 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Kitara Piin 1102 | Public | 9.32% | 0.00 |
| Varalwar Sandeep | Promoter | 2.80% | 0.00 |
| William F Harvey | Public | 1.66% | 0.00 |
| Subhash Varalwar | Promoter | 1.64% | 0.00 |
| Sameer Mahendra Sampat | Public | 1.63% | 0.00 |
| Amicorp Capital (Mauritius) Limited | FII | 1.46% | New |
| Ashish Bharatkumar Shah | Public | 1.43% | 0.00 |
| Monarch Networth Finserve Private Limited | Public | 1.23% | 0.00 |
| Jagat Foods Private Limited | Public | 1.11% | New |
| Sheetal Varalwar | Promoter | 0.82% | 0.00 |
| Bbr Projects Private Limited | Promoter | 0.52% | 0.00 |
| Manohar Rao Varalwar | Promoter | 0.52% | 0.00 |
| S Raghunandan | Promoter | 0.38% | 0.00 |
| Madhavi Varalwar | Promoter | 0.24% | 0.00 |
| Mamatha Gurnukar | Promoter | 0.18% | −0.06 |
| Vijaykumar Varalwar | Promoter | 0.18% | 0.00 |
| Neelima Vijaya Varalwar | Promoter | 0.12% | 0.00 |
| Chandrashekharrao Sudigali | Promoter | 0.06% | 0.00 |
| Varalwar Padma | Promoter | 0.04% | 0.00 |
| Sujatha Varalwar | Promoter | 0.03% | 0.00 |
| Vithabai Varalwar | Promoter | 0.03% | 0.00 |
| Krone Finstock Pvt Ltd | Public | Exited | — |
| K India Opportunities Fund Limited Pcc - Cell S | FII | Exited | — |
| Satish Gooty Agraharam | Promoter | Exited | −0.13 |
Promoters held 7.54% of Vivimed Labs at the end of the Mar 2026 quarter, down 13.37 percentage points from 20.91% a year earlier.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 1.65% (unchanged at 1.65% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
Yes. 15.25% of promoter shares were pledged at the end of the Mar 2026 quarter.
Vivimed Labs had 47,506 shareholders at the end of the Mar 2026 quarter, against 48,971 a year earlier.
Kitara Piin 1102 (Public) held 9.32% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.